Nj State Employees Deferred Compensation Plan Madrigal Pharmaceuticals, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $800 Million
- Q4 2024
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 1,500 shares of MDGL stock, worth $505,905. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$505,905
Previous $318,000
45.28%
% of portfolio
0.06%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding MDGL
# of Institutions
335Shares Held
22.2MCall Options Held
960KPut Options Held
940K-
Janus Henderson Group PLC London, X02.21MShares$745 Million0.36% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$689 Million38.14% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$684 Million9.12% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$672 Million10.03% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$666 Million6.75% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.77B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...